IQVIA Holdings Inc. (0JDM.L)
0JDM.L Stock Price Chart
Explore IQVIA Holdings Inc. interactive price chart. Choose custom timeframes to analyze 0JDM.L price movements and trends.
0JDM.L Company Profile
Discover essential business fundamentals and corporate details for IQVIA Holdings Inc. (0JDM.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
29 Jan 2018
Employees
89.00K
Website
https://www.iqvia.comCEO
Ari Bousbib
Description
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
0JDM.L Financial Timeline
Browse a chronological timeline of IQVIA Holdings Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 May 2026
Upcoming earnings on 4 Feb 2026
Upcoming earnings on 29 Oct 2025
Upcoming earnings on 22 Jul 2025
Revenue estimate is $3.96B.
Earnings released on 6 May 2025
EPS came in at $2.70 surpassing the estimated $2.63 by +2.66%, while revenue for the quarter reached $3.83B, missing expectations by -2.71%.
Earnings released on 6 Feb 2025
EPS came in at $2.42 falling short of the estimated $3.11 by -22.19%, while revenue for the quarter reached $3.96B, beating expectations by +0.76%.
Earnings released on 31 Oct 2024
EPS came in at $1.55 falling short of the estimated $2.82 by -45.04%, while revenue for the quarter reached $3.89B, beating expectations by +0.71%.
Earnings released on 22 Jul 2024
EPS came in at $1.97 falling short of the estimated $2.56 by -23.05%, while revenue for the quarter reached $3.81B, beating expectations by +0.65%.
Earnings released on 2 May 2024
EPS came in at $1.56 falling short of the estimated $2.49 by -37.35%, while revenue for the quarter reached $3.74B, beating expectations by +0.96%.
Earnings released on 13 Mar 2024
EPS came in at $2.54 falling short of the estimated $2.82 by -9.93%, while revenue for the quarter reached $3.87B, beating expectations by +1.88%.
Earnings released on 1 Nov 2023
EPS came in at $1.63 falling short of the estimated $2.44 by -33.20%, while revenue for the quarter reached $3.74B, missing expectations by -0.88%.
Earnings released on 1 Aug 2023
EPS came in at $1.59 falling short of the estimated $2.38 by -33.19%, while revenue for the quarter reached $3.72B, beating expectations by +0.30%.
Earnings released on 27 Apr 2023
EPS came in at $1.53 falling short of the estimated $2.41 by -36.51%, while revenue for the quarter reached $3.64B, beating expectations by +0.76%.
Earnings released on 10 Feb 2023
EPS came in at $1.20 falling short of the estimated $2.76 by -56.52%, while revenue for the quarter reached $3.75B, beating expectations by +1.06%.
Earnings released on 30 Sept 2022
EPS came in at $1.49 falling short of the estimated $2.39 by -37.66%, while revenue for the quarter reached $3.55B, beating expectations by +0.38%.
Earnings released on 30 Jun 2022
EPS came in at $1.34 falling short of the estimated $2.38 by -43.70%, while revenue for the quarter reached $3.55B, beating expectations by +1.66%.
Earnings released on 20 Apr 2022
EPS came in at $1.68 falling short of the estimated $2.42 by -30.58%, while revenue for the quarter reached $3.57B, beating expectations by +0.85%.
Dividend declared on 15 Mar 2022
A dividend of $0.29 per share was announced, adjusted to $0.29.
Earnings released on 8 Feb 2022
EPS came in at $1.63 falling short of the estimated $2.43 by -32.92%, while revenue for the quarter reached $3.64B, beating expectations by +1.23%.
Earnings released on 21 Oct 2021
EPS came in at $0.90, while revenue for the quarter reached $3.44B.
Earnings released on 30 Sept 2021
EPS came in at $1.34, while revenue for the quarter reached $3.39B.
Earnings released on 31 Mar 2021
EPS came in at $1.09, while revenue for the quarter reached $3.41B.
Earnings released on 31 Dec 2020
EPS came in at $0.61, while revenue for the quarter reached $3.30B.
Earnings released on 30 Sept 2020
EPS came in at $0.52, while revenue for the quarter reached $2.79B.
0JDM.L Stock Performance
Access detailed 0JDM.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.